About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2025 Clareo Health. All rights reserved.

UNKNOWNPhase 4

Halodine Nasal Antiseptic in Patients With COVID-19

A Phase 4 Study to Evaluate Nasopharyngeal SARS-CoV-2 Viral Shedding After Halodine Nasal Antiseptic in Patients With COVID-19

NCT04517188•Halodine LLC

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

SARS-CoV-2 Infection

Interventions

Povidone-Iodine Solution 1.25% w/w [0.125% available iodine] USP

Key Dates

Start Date

April 1, 2021

Primary Completion Date

July 1, 2021

Completion Date

July 1, 2021

Last Updated

February 10, 2021

Related Studies

RECRUITINGPhase 3

Randomized Double-Blind Placebo-Controlled Trial EValuating Baricitinib on PERSistent NEurologic and Cardiopulmonary Symptoms of Long COVID

NCT06631287

Long COVIDSars-CoV-2 Infection+2 more

RECRUITINGPhase 1

T Cell Therapy Opposing Novel COVID-19 Infection in Immunocompromised Patients

NCT05141058

SARS-CoV-2 Infection

RECRUITINGPhase 3

A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease

NCT06679140

COVID-19 SARS-CoV-2 Infection

Clinical Outcomes and Pharmacotherapy Effectiveness in the VA Health Care System (COPE-VA)

NCT06160128

COVID-19, SARS-CoV-2 InfectionRSV+1 more

RECRUITINGPhase 3

A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age

NCT07300839

COVID-19SARS-COV-2 Infection

Physiology of Long COVID-19 and the Impact of Cardiopulmonary Rehabilitation on Quality-of-Life and Functional Capacity

NCT05566483

Post-acute Sequelae of SARS-CoV-2 Infection

View all related studies

Contacts

Samuel B Barone, MD

CONTACT

2023908590 sbarone@halodine.com

Sponsors

Lead Sponsor

Halodine LLC

Detailed Description

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 10, 2021Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions